Lauppe, Rosa, et al. “Use of ALK-Tyrosine Kinase Inhibitors (ALK TKI) in Clinical Practice, Overall Survival, and Treatment Duration – a Swedish Nationwide Retrospective Study”. Acta Oncologica, vol. 61, no. 11, Nov. 2022, pp. 1354-61, doi:10.1080/0284186X.2022.2133972.